Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Jun;64(6):2070–2078. doi: 10.1128/iai.64.6.2070-2078.1996

Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene.

C L Pickett 1, E C Pesci 1, D L Cottle 1, G Russell 1, A N Erdem 1, H Zeytin 1
PMCID: PMC174038  PMID: 8675309

Abstract

Campylobacter jejuni produces a toxin called cytolethal distending toxin (CDT). The genes encoding this toxin in C. jejuni 81-176 were cloned and sequenced. The nucleotide sequence of the genes revealed that there are three genes, cdtA, cdtB, and cdtC, encoding proteins with predicted sizes of 30,11-6, 28,989, and 21,157 Da, respectively. All three proteins were found to be related to the Escherichia coli CDT proteins, yet the amino acid sequences have diverged significantly. All three genes were required for toxic activity in a HeLa cell assay. HeLa cell assays of a variety of C. jejuni and C. coli strains suggested that most C. jejuni strains produce significantly higher CDT titers than do C. coli strains. Southern hybridization experiments demonstrated that the cdtB gene is present on a 6.0-kb ClaI fragment in all but one of the C. jejuni strains tested; the cdtB gene was on a 6.9-kb ClaI fragment in one strain. The C. jejuni 81-176 cdtB probe hybridized weakly to DNAs from C. coli strains. The C. jejuni 81-176 cdtB probe did not hybridize to DNAs from representative C. fetus, C. lari, C. "upsaliensis," and C. hyointestinalis strains, although the HeLa cell assay indicated that these strains make CDT. PCR experiments indicated the probable presence of cdtB sequences in all of these Campylobacter species.

Full Text

The Full Text of this article is available as a PDF (638.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black R. E., Levine M. M., Clements M. L., Hughes T. P., Blaser M. J. Experimental Campylobacter jejuni infection in humans. J Infect Dis. 1988 Mar;157(3):472–479. doi: 10.1093/infdis/157.3.472. [DOI] [PubMed] [Google Scholar]
  2. Blaser M. J., Perez G. P., Smith P. F., Patton C., Tenover F. C., Lastovica A. J., Wang W. I. Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis. 1986 Mar;153(3):552–559. doi: 10.1093/infdis/153.3.552. [DOI] [PubMed] [Google Scholar]
  3. Blaser M. J., Reller L. B., Luechtefeld N. W., Wang W. L. Campylobacter enteritis in Denver. West J Med. 1982 Apr;136(4):287–290. [PMC free article] [PubMed] [Google Scholar]
  4. Butzler J. P., Skirrow M. B. Campylobacter enteritis. Clin Gastroenterol. 1979 Sep;8(3):737–765. [PubMed] [Google Scholar]
  5. Dong J. M., Taylor J. S., Latour D. J., Iuchi S., Lin E. C. Three overlapping lct genes involved in L-lactate utilization by Escherichia coli. J Bacteriol. 1993 Oct;175(20):6671–6678. doi: 10.1128/jb.175.20.6671-6678.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Edmonds P., Patton C. M., Griffin P. M., Barrett T. J., Schmid G. P., Baker C. N., Lambert M. A., Brenner D. J. Campylobacter hyointestinalis associated with human gastrointestinal disease in the United States. J Clin Microbiol. 1987 Apr;25(4):685–691. doi: 10.1128/jcm.25.4.685-691.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Goossens H., Pot B., Vlaes L., Van den Borre C., Van den Abbeele R., Van Naelten C., Levy J., Cogniau H., Marbehant P., Verhoef J. Characterization and description of "Campylobacter upsaliensis" isolated from human feces. J Clin Microbiol. 1990 May;28(5):1039–1046. doi: 10.1128/jcm.28.5.1039-1046.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Guerrant R. L., Wanke C. A., Pennie R. A., Barrett L. J., Lima A. A., O'Brien A. D. Production of a unique cytotoxin by Campylobacter jejuni. Infect Immun. 1987 Oct;55(10):2526–2530. doi: 10.1128/iai.55.10.2526-2530.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jobling M. G., Holmes R. K. Construction of vectors with the p15a replicon, kanamycin resistance, inducible lacZ alpha and pUC18 or pUC19 multiple cloning sites. Nucleic Acids Res. 1990 Sep 11;18(17):5315–5316. doi: 10.1093/nar/18.17.5315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johnson W. M., Lior H. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb Pathog. 1988 Feb;4(2):115–126. doi: 10.1016/0882-4010(88)90053-8. [DOI] [PubMed] [Google Scholar]
  11. Johnson W. M., Lior H. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb Pathog. 1988 Feb;4(2):103–113. doi: 10.1016/0882-4010(88)90052-6. [DOI] [PubMed] [Google Scholar]
  12. Konkel M. E., Babakhani F., Joens L. A. Invasion-related antigens of Campylobacter jejuni. J Infect Dis. 1990 Oct;162(4):888–895. doi: 10.1093/infdis/162.4.888. [DOI] [PubMed] [Google Scholar]
  13. Korlath J. A., Osterholm M. T., Judy L. A., Forfang J. C., Robinson R. A. A point-source outbreak of campylobacteriosis associated with consumption of raw milk. J Infect Dis. 1985 Sep;152(3):592–596. doi: 10.1093/infdis/152.3.592. [DOI] [PubMed] [Google Scholar]
  14. Mahajan S., Rodgers F. G. Isolation, characterization, and host-cell-binding properties of a cytotoxin from Campylobacter jejuni. J Clin Microbiol. 1990 Jun;28(6):1314–1320. doi: 10.1128/jcm.28.6.1314-1320.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Moore M. A., Blaser M. J., Perez-Perez G. I., O'Brien A. D. Production of a Shiga-like cytotoxin by Campylobacter. Microb Pathog. 1988 Jun;4(6):455–462. doi: 10.1016/0882-4010(88)90030-7. [DOI] [PubMed] [Google Scholar]
  16. Nagel de Zwaig R., Luria S. E. Genetics and physiology of colicin-tolerant mutants of Escherichia coli. J Bacteriol. 1967 Oct;94(4):1112–1123. doi: 10.1128/jb.94.4.1112-1123.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Patton C. M., Shaffer N., Edmonds P., Barrett T. J., Lambert M. A., Baker C., Perlman D. M., Brenner D. J. Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States. J Clin Microbiol. 1989 Jan;27(1):66–73. doi: 10.1128/jcm.27.1.66-73.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Perez Perez G. I., Blaser M. J. Lipopolysaccharide characteristics of pathogenic campylobacters. Infect Immun. 1985 Feb;47(2):353–359. doi: 10.1128/iai.47.2.353-359.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Perez-Perez G. I., Cohn D. L., Guerrant R. L., Patton C. M., Reller L. B., Blaser M. J. Clinical and immunologic significance of cholera-like toxin and cytotoxin production by Campylobacter species in patients with acute inflammatory diarrhea in the USA. J Infect Dis. 1989 Sep;160(3):460–468. doi: 10.1093/infdis/160.3.460. [DOI] [PubMed] [Google Scholar]
  20. Pickett C. L., Auffenberg T., Pesci E. C., Sheen V. L., Jusuf S. S. Iron acquisition and hemolysin production by Campylobacter jejuni. Infect Immun. 1992 Sep;60(9):3872–3877. doi: 10.1128/iai.60.9.3872-3877.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pickett C. L., Cottle D. L., Pesci E. C., Bikah G. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect Immun. 1994 Mar;62(3):1046–1051. doi: 10.1128/iai.62.3.1046-1051.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pugsley A. P. The complete general secretory pathway in gram-negative bacteria. Microbiol Rev. 1993 Mar;57(1):50–108. doi: 10.1128/mr.57.1.50-108.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rennie R. P., Strong D., Taylor D. E., Salama S. M., Davidson C., Tabor H. Campylobacter fetus diarrhea in a Hutterite colony: epidemiological observations and typing of the causative organism. J Clin Microbiol. 1994 Mar;32(3):721–724. doi: 10.1128/jcm.32.3.721-724.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Riley L. W., Finch M. J. Results of the first year of national surveillance of Campylobacter infections in the United States. J Infect Dis. 1985 May;151(5):956–959. doi: 10.1093/infdis/151.5.956. [DOI] [PubMed] [Google Scholar]
  25. Scott D. A., Kaper J. B. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun. 1994 Jan;62(1):244–251. doi: 10.1128/iai.62.1.244-251.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tauxe R. V., Patton C. M., Edmonds P., Barrett T. J., Brenner D. J., Blake P. A. Illness associated with Campylobacter laridis, a newly recognized Campylobacter species. J Clin Microbiol. 1985 Feb;21(2):222–225. doi: 10.1128/jcm.21.2.222-225.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wahl G. M., Berger S. L. Screening colonies or plaques with radioactive nucleic acid probes. Methods Enzymol. 1987;152:415–423. doi: 10.1016/0076-6879(87)52048-1. [DOI] [PubMed] [Google Scholar]
  28. Wassenaar T. M., Bleumink-Pluym N. M., van der Zeijst B. A. Inactivation of Campylobacter jejuni flagellin genes by homologous recombination demonstrates that flaA but not flaB is required for invasion. EMBO J. 1991 Aug;10(8):2055–2061. doi: 10.1002/j.1460-2075.1991.tb07736.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES